| 英文名称 | 中文名称 | CAS | MF |
|
EasyxpressNmrProteinSynthesisKit-F
|
|
|
|
|
EasyxpressNmrProteinSynthesisKit-P
|
|
|
|
|
EasyxtalDg-Tool(100)
|
|
|
|
|
EasyxpressProteinSynthesisMegaKit
|
|
|
|
|
EasyxtalTool(100)
|
|
|
|
|
EasyxpressNmrProteinSynthesisKit-D
|
|
|
|
|
EasyxpressPix3.0Vector
|
|
|
|
|
EasyxpressNmrProteinSynthesisKit-Y
|
|
|
|
|
EasyxtalDg-Tool(50)
|
|
|
|
|
EasyxtalTool(50)
|
|
|
|
|
EasyxpressProteinSynthesisInsectKit
|
|
|
|
|
EasyxtalDg-CrystalsupportX-Seal(25)
|
|
|
|
|
EasyxpressNmrProteinSynthesisKit-A
|
|
|
|
|
EasyxtalToolX-Seal(50)
|
|
|
|
|
EasyxpressNmrProteinSynthesisKit-I
|
|
|
|
|
EasyxpressNmrProteinSynthesisKit-C
|
|
|
|
|
EasyxpressNmrProteinSynthesisKit-L
|
|
|
|
|
EasyxtalToolX-Seal(100)
|
|
|
|
|
EasyxpressNmrProteinSynthesisKit-M
|
|
|
|
|
EasyxpressSite-SpecificBiotinKit
|
|
|
|
|
EasyxtalPre-ScreenAssay
|
|
|
|
|
EasyxtalSealingTapes(100)
|
|
|
|
|
EasyxtalMicroplates
|
|
|
|
|
EasyxtalDg-Crystalsupport(25)
|
|
|
|
|
EasyxpressProteinSynthesisMaxiKit
|
|
|
|
|
EAT-2 protein
|
|
|
|
|
EAT-16 protein
|
|
|
|
|
EAT-20 protein
|
|
|
|
|
EAT-5 protein
|
|
|
|
|
EAT-4, Rat (Vesicular Type Transporters for Glutamate, VGLUT) Control Peptide
|
|
|
|
|
EAT2, Recombinant, Human
|
|
|
|
|
ECBALLIUM ELATERIUM
|
喷瓜(ECBALLIUM ELATERIUM)
|
|
|
|
ECBALLIUM ELATERIUM FRUIT EXTRACT
|
喷瓜(ECBALLIUM ELATERIUM)果提取物
|
|
|
|
(5E)-Calcipotriene-d4
|
|
|
C27H40O3
|
|
(5E)-Calcipotriene
|
5,6-反式-卡泊三醇
|
113082-99-8
|
C27H40O3
|
|
ECALCIDENUM
|
|
150337-94-3
|
C29H45NO3
|
|
EAT-4 (Vesicular Type Transporters for Glutamate, VGLUT)
|
|
|
|
|
ecalectin
|
|
|
|
|
EBL, BIOTINYLATED
|
|
|
|
|
ecallantide
|
艾卡拉肽
|
460738-38-9
|
C305H442N88O91S8
|
|
EC 1.1.1.8 AND EC 5.3.1.1
|
|
|
|
|
EC 2.7.1.1 AND EC 1.1.1.49
|
EC 2.7.1.1 AND EC 1.1.1.49
|
|
|
|
ECALYPTUS OIL >80%(REAGENT / STANDARD GRADE)
|
|
|
|
|
ECBC protocol
|
|
|
|
|
Ecamsule Triethanolamine (200 mg)
|
依莰舒三乙醇胺
|
92841-53-7
|
C40H64N2O14S2
|
|
Ecamsule Related Compound F (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid)
|
Ecamsule Related Compound F (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid)
|
|
|
|
Ecamsule Related Compound G (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt)
|
Ecamsule Related Compound G (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt)
|
|
|
|
Ecamsule Solution (0.5 mL)
|
Ecamsule Solution (0.5 mL)
|
|
|
|
Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate)
|
Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate)
|
|
|
|
Ecamsule
|
依莰舒
|
|
|
|
ecamulin
|
|
|
|
|
EBL FLUORESCEIN LABELED
|
|
|
|
|
ECAPP protocol
|
|
|
|
|
e-Caprolactone--d6
|
e-Caprolactone--d6
|
1219802-08-0
|
C6H4D6O2
|
|
ECA39 protein
|
|
|
|
|
ECA39 protein, Saccharomyces
|
|
|
|
|
E-CAPROLACTONE-3,3,4,4,5,5-D6
|
|
|
C6H4D6O2
|
|
ECA40 protein
|
|
|
|
|
(E)-3-[[[(2-Carboxyethyl)thio][3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]methyl]thio]propanoic Acid 1-Methyl Ester
|
(E)-3-[[[(2-Carboxyethyl)thio][3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]methyl]thio]propanoic Acid 1-Methyl Ester
|
131774-44-2
|
C25H24ClNO4S2
|
|
3-[(1E)-2-[4-[[(2-carboxyethyl)aMino]carbonyl]phenyl]diazenyl] Balsalazide
|
巴柳氮杂质1
|
1242567-11-8
|
C27H24N6O9
|
|
2'-[(1E)-2-[4-[[(2-carboxyethyl)aMino]carbonyl]phenyl]diazenyl] Balsalazide
|
巴柳氮USP杂质3
|
1346606-53-8
|
C27H24N6O9
|
|
( E )-4-((5-carboxy-3,3-diMethyl-1-octyl-3H-indoliuM-2-yl)Methylene)-2-((E )-(1-ethyl-3,3-diMethylindolin-2-ylidene)Methyl)-3-oxocyclobut-1-enolate
|
SQ01
|
951248-19-4
|
C37H44N2O4
|
|
( E )-4-((5-carboxy-3,3-diMethyl-1-octyl-3H-indoliuM-2-yl)Methylene)-2-((E )-(3-ethyl-1,1-diMethyl-1H-benzo[e]indol-2(3H)-ylidene)Methyl)-3-oxocyclobut-1-enolate
|
SQ02
|
1240041-84-2
|
C41H46N2O4
|
|
(E)-5-(4-carboxy-3-Methylbut-3-enyl)-5,6,8a-triMethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylic acid
|
|
170809-24-2
|
C20H30O3
|
|
(E)-1-(5-Carboxypentyl)-4-(2-(7-(diethylaMino)-2-oxo-2H-chroMen-3-yl)vinyl)pyridiniuM-3-sulfonate
|
CYTO 520
|
|
C26H30N2O7S
|
|
(E)-1-(5-Carboxypentyl)-6-(2-(7-(diethylaMino)-2-oxo-2H-chroMen-3-yl)vinyl)pyridiniuM-3-sulfonate
|
CYTO 500
|
|
C26H30N2O7S
|
|
(E)-5-(2-CARBOXVINYL)URACIL
|
|
|
C7H6N2O4
|
|
4-[((5-[(E)-2-CARBOXYVINYL]-2-METHOXYPHENYL)SULFONYL)AMINO]BENZOIC ACID
|
|
|
C17H15NO7S
|
|
5-([4-[(E)-2-CARBOXYVINYL]-2-METHOXYPHENOXY]METHYL)-2-FUROIC ACID
|
|
|
C16H14O7
|
|
8-(2-[(E)-1-CARBOXYETHYLIDENE]HYDRAZINO)QUINOLINIUM CHLORIDE
|
|
477762-38-2
|
C12H12ClN3O2
|
|
(E)-5-[2-(2-CARBOXYVINYL)]-2'-DEOXYURIDINE N-HYDROXY-SUCCIMIDE ESTER
|
2'-脱氧-5-[(1E)-3-[(2,5-二氧代-1-吡咯烷基)氧基]-3-氧代-1-丙烯基]尿苷
|
869355-24-8
|
C16H17N3O9
|
|
9-((E)-2-CARBAMOYL-2-CYANOVINYL) JULOLID
|
|
142978-19-6
|
C16H17N3O
|
|
(2E)-3-(3-([(3-CARBOXYPROPYL)AMINO]SULFONYL)-4-METHOXYPHENYL)ACRYLIC ACID
|
|
|
C14H17NO7S
|
|
(E)-5-(2-CARBOMETHOXYVINYL)-2'-DEOXYURIDINE
|
(E)-5-(2-甲氧羰基乙烯基)-2'-脱氧尿苷
|
86163-17-9
|
C13H16N2O7
|
|
(E)-5-CARBOXYVINYL URACIL
|
(E)-5-CARBOXYVINYL URACIL
|
57412-59-6
|
C7H6N2O4
|
|
(E)-7-Carboxy-3-((6-(4-methoxyphenyl)-5-hexenyl)oxy)-9-oxo-9H-xanthene -4-propanoic acid
|
148291-65-0
|
148291-65-0
|
C30H28O8
|
|
2-[(E)-2-Carboxyethenyl]benzoic acid
|
|
18454-53-0
|
C10H8O4
|
|
3-[2-[(E)-[3-(2-carboxyethyl)-5-[(4-ethenyl-3-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methylpyrrol-2-ylidene]methyl]-5-[(3-ethyl-4-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
|
|
3947-38-4
|
C33H40N4O6
|
|
2-{[(E)-3-carboxy-2-propenoyl]amino}benzenecarboxylic acid
|
|
|
C11H9NO5
|
|
4-{[(E)-3-carboxy-2-propenoyl]amino}benzenecarboxylic acid
|
|
|
C11H9NO5
|
|
2-[(E)-1-carboxy-2-(3,4-dichlorophenyl)ethenyl]benzoic acid
|
|
75227-04-2
|
C16H10Cl2O4
|
|
4-((E)-[3-(2-CARBOXYETHYL)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE]METHYL)BENZOIC ACID
|
|
|
C14H11NO5S2
|
|
(E)-3-((((6-(2-carboxyethenyl)-5-((8-(4-methoxyphenyl)octyl)oxy)-2-pyridinyl)methyl)thio)methyl)benzoic acid
|
|
150399-22-7
|
C32H37NO6S
|
|
(E)-carbamoyliminourea
|
|
97707-96-5
|
C2H4N4O2
|
|
4-[((3-[(E)-2-CARBOXYVINYL]PHENYL)AMINO)SULFONYL]BENZOIC ACID
|
|
|
C16H13NO6S
|
|
8-(E)-[2-CARBOXY-1-(TRIFLUOROMETHYL)ETHEN-1-YL]-4-(TRIFLUOROMETHYL)COUMARIN
|
|
|
C14H6F6O4
|
|
(E)-5-(2-CARBOXYVINYL)-2'-DEOXYURIDINE
|
(2E)-3-[1-(2-脱氧-BETA-D-赤式戊呋喃糖基)-1,2,3,4-四氢-2,4-二氧代-5-嘧啶基]-2-丙烯酸
|
74131-06-9
|
C12H14N2O7
|
|
4-[(1E)-2-carbamoyleth-1-en-1-yl]benzoic acid
|
|
|
C10H9NO3
|
|
3-(5-((E)-2-carboxyvinyl)furan-2-yl)-4-chlorobenzoic acid
|
|
|
C14H9ClO5
|
|
3-{[(E)-3-carboxy-2-propenoyl]amino}benzenecarboxylic acid
|
|
|
C11H9NO5
|
|
(2E)-3-[4-(carbamoylmethoxy)phenyl]prop-2-enoic acid
|
|
|
C11H11NO4
|
|
2-[(1E)-2-carboxyeth-1-en-1-yl]benzoic acid
|
|
|
C10H8O4
|
|
(E)-5-(2-CARBOXYVINYL)-2,4-DIMETHOXYPYRIMIDINE
|
(E)-5-(2-羰基乙烯)-2,4-二甲氧基嘧啶
|
119923-27-2
|
C9H10N2O4
|
|
(E)-5-(2-CARBOMETHOXYVINYL)URIDINE
|
(E)-5-(2-CARBOMETHOXYVINYL)URIDINE
|
58931-19-4
|
C13H16N2O8
|
|
5-(E-2-CARBOMETHOXYVINYL)-5'-O-(4,4'-DIMETHOXYTRITYL)-2'-DEOXYURIDINE, 3'-[(2-CYANOETHYL)-(N,N-DIISOPROPYL)]PHOSPHORAMIDITE
|
3-[1-[5-O-[二(4-甲氧基苯基)苯基甲基]-3-O-[[二异丙基氨基](2-氰基乙氧基)膦基]-2-脱氧-BETA-D-赤式-呋喃戊糖基]-1,2,3,4-四氢-2,4-二氧代-5-嘧啶基]-2-丙烯酸甲酯
|
198080-38-5
|
C43H51N4O10P
|
|
(E)-5-(2-CARBOXYVINYL)URIDINE
|
(E)-5-(2-CARBOXYVINYL)URIDINE
|
99394-52-2
|
C12H14N2O8
|
|
4-((E)-2-CARBAMOYL-VINYL)-PIPERIDINE-1-CARBOXYLIC ACID METHYL ESTER
|
|
|
C10H16N2O3
|
|
(E)-4-[5-(CARBOXYMETHYL)-2-HYDROXYANILINO]-4-OXO-2-BUTENOIC ACID
|
|
866019-68-3
|
C12H11NO6
|
|
[E]-5-(2-CARBOMETHOXYVINYL)-5'-O-(DIMETHOXYTRITYL)-2'-DEOXYURIDINE
|
(2E)-3-[1-[5-O-[二(4-甲氧基苯基)苯基甲基]-2-脱氧-BETA-D-赤式-呋喃戊糖基]-1,2,3,4-四氢-2,4-二氧代-5-嘧啶基]-2-丙烯酸甲酯
|
869355-22-6
|
C34H34N2O9
|
|
8-(E)-[2-CARBOXY-1-(TRIFLUOROMETHYL)ETHEN-1-YL]-6-METHYL-4-(TRIFLUOROMETHYL)COUMARIN
|
|
|
C15H8F6O4
|